Видео ютуба по тегу Il-23

Targeting the IL-12/23 Pathway in IBD
Targeting the IL-12/23 Pathway in IBD
Discussing Risankizumb, Differences in IL-23 Inhibitor Epitopes with Christopher Bunick, MD, PhD
Discussing Risankizumb, Differences in IL-23 Inhibitor Epitopes with Christopher Bunick, MD, PhD
Understanding the use of IL12/IL23 targeted biologics
Understanding the use of IL12/IL23 targeted biologics
IL-23s: Psoriasis therapy overview
IL-23s: Psoriasis therapy overview
The role of Il-23 in Autoimmunity
The role of Il-23 in Autoimmunity
Targeting IL-12/IL-23 in Crohn’s Disease
Targeting IL-12/IL-23 in Crohn’s Disease
Efficacy of IL-23 Inhibitors in Plaque Psoriasis
Efficacy of IL-23 Inhibitors in Plaque Psoriasis
WATCH NOW: Clean-Up on IL-23: The Science of Inflammatory Targets & Treatment Decision-making in IBD
WATCH NOW: Clean-Up on IL-23: The Science of Inflammatory Targets & Treatment Decision-making in IBD
Positioning anti-IL-12 and anti-IL-23 inhibitors
Positioning anti-IL-12 and anti-IL-23 inhibitors
Safety and Efficacy of IL-23 Inhibitors in Plaque Psoriasis
Safety and Efficacy of IL-23 Inhibitors in Plaque Psoriasis
FAQ: What is The Role of IL23/IL17 Axis in Rheumatic Disease
FAQ: What is The Role of IL23/IL17 Axis in Rheumatic Disease
From Pathways to Practice: Exploring IL-23 Inhibitors for Inflammatory Bowel Disease
From Pathways to Practice: Exploring IL-23 Inhibitors for Inflammatory Bowel Disease
Treating Plaque Psoriasis: IL-17 and IL-23 Inhibitors
Treating Plaque Psoriasis: IL-17 and IL-23 Inhibitors
IL 23
IL 23
Hitting the Target with IL-23 Inhibitors in Psoriatic Arthritis
Hitting the Target with IL-23 Inhibitors in Psoriatic Arthritis
IL23 Inhibitors and COVID-19
IL23 Inhibitors and COVID-19
Selecting from IL-23s
Selecting from IL-23s
Visualizing the Future: Advances in IL-23-Targeteding Therapies in the Treatment of IBD
Visualizing the Future: Advances in IL-23-Targeteding Therapies in the Treatment of IBD
Psoriasis and beyond: targeting the IL-17 pathway
Psoriasis and beyond: targeting the IL-17 pathway
IL-23 Inhibitors in Plaque Psoriasis
IL-23 Inhibitors in Plaque Psoriasis
WCH23: IL-17 vs IL-23 Blockers – Why and When?
WCH23: IL-17 vs IL-23 Blockers – Why and When?
New Biologic Therapies that Target the IL-12/23 Pathway
New Biologic Therapies that Target the IL-12/23 Pathway
Risankizumab vs. Ustekinumab for Psoriasis
Risankizumab vs. Ustekinumab for Psoriasis
IL23 & IL12/23 Inhibitors: An Overview
IL23 & IL12/23 Inhibitors: An Overview